179 related articles for article (PubMed ID: 33762460)
1. [Tumefactive demyelinating lesion (TDL)].
Nakajima A; Kawachi I
No Shinkei Geka; 2021 Mar; 49(2):376-382. PubMed ID: 33762460
[TBL] [Abstract][Full Text] [Related]
2. Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H; Shirah B; Alassiri A
Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
[TBL] [Abstract][Full Text] [Related]
3. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.
Ongphichetmetha T; Aungsumart S; Siritho S; Apiwattanakul M; Tanboon J; Rattanathamsakul N; Prayoonwiwat N; Jitprapaikulsan J
Sci Rep; 2024 Jan; 14(1):1426. PubMed ID: 38228919
[TBL] [Abstract][Full Text] [Related]
4. Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions.
Ayrignac X; Rigau V; Lhermitte B; Vincent T; de Champfleur NM; Carra-Dalliere C; Charif M; Collongues N; de Seze J; Hebbadj S; Ahle G; Oesterlé H; Cotton F; Durand-Dubief F; Marignier R; Vukusic S; Taithe F; Cohen M; Guennoc AM; Kerbrat A; Edan G; Carsin-Nicol B; Allou T; Sablot D; Thouvenot E; Ruet A; Magy L; Boncoeur-Martel MP; Labauge P; Kremer S
J Neurol; 2019 Jul; 266(7):1743-1755. PubMed ID: 31016376
[TBL] [Abstract][Full Text] [Related]
5. Callosal lesions on magnetic resonance imaging with multiple sclerosis, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis.
Cai MT; Zhang YX; Zheng Y; Fang W; Ding MP
Mult Scler Relat Disord; 2019 Jul; 32():41-45. PubMed ID: 31030018
[TBL] [Abstract][Full Text] [Related]
6. Atypical Pediatric Demyelinating Diseases of the Central Nervous System.
Troxell RM; Christy A
Curr Neurol Neurosci Rep; 2019 Nov; 19(12):95. PubMed ID: 31773416
[TBL] [Abstract][Full Text] [Related]
7. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases.
Codjia P; Ayrignac X; Carra-Dalliere C; Cohen M; Charif M; Lippi A; Collongues N; Corti L; De Seze J; Lebrun C; Vukusic S; Durand-Dubief F; Labauge P;
Mult Scler Relat Disord; 2019 Feb; 28():109-116. PubMed ID: 30592992
[TBL] [Abstract][Full Text] [Related]
9. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P
J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666
[TBL] [Abstract][Full Text] [Related]
10. Frontal Tumefactive Demyelinating Lesion Mimicking Glioblastoma Differentiated by Methionine Positron Emission Tomography.
Yasuda S; Yano H; Kimura A; Suzui N; Nakayama N; Shinoda J; Iwama T
World Neurosurg; 2018 Nov; 119():244-248. PubMed ID: 30114544
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology.
Saridas F; Mesut G; Ceylan CY; Ozpar R; Ozsen M; Koc ER; Tolunay S; Hakyemez B; Turan OF
Mult Scler Relat Disord; 2024 May; 85():105537. PubMed ID: 38460252
[TBL] [Abstract][Full Text] [Related]
12. Tumefactive Demyelinating Lesions and Pregnancy.
Plantone D; Piantadosi C; Ruggieri S; Anelli V; Koudriavtseva T
Neurol India; 2019; 67(6):1519-1521. PubMed ID: 31857550
[TBL] [Abstract][Full Text] [Related]
13. A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: doubtful CT, MRI, and bioptic findings: Case report and literature review.
Conforti R; Capasso R; Galasso R; Cirillo M; Taglialatela G; Galasso L
Medicine (Baltimore); 2016 Sep; 95(36):e4585. PubMed ID: 27603348
[TBL] [Abstract][Full Text] [Related]
14. Catastrophic tumefactive acute disseminated encephalomyelitis in patient with dengue virus: a case report.
Chayanopparat S; Jitprapaikulsan J; Ongphichetmetha T
J Neurovirol; 2024 May; ():. PubMed ID: 38778005
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in Tumefactive demyelinating lesions: A retrospective study.
Plowman RS; Varma H
J Neurol Sci; 2021 Sep; 428():117591. PubMed ID: 34333380
[TBL] [Abstract][Full Text] [Related]
16. Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.
Vakrakou AG; Brinia ME; Svolaki I; Argyrakos T; Stefanis L; Kilidireas C
Front Neurol; 2022; 13():868525. PubMed ID: 35418930
[TBL] [Abstract][Full Text] [Related]
17. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1643-1649. PubMed ID: 30115676
[TBL] [Abstract][Full Text] [Related]
18. A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion.
Miyaue N; Yamanishi Y; Tada S; Ando R; Yabe H; Nagai M; Nomoto M
Mult Scler Relat Disord; 2019 Jun; 31():62-64. PubMed ID: 30933712
[TBL] [Abstract][Full Text] [Related]
19. CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma.
Ikeguchi R; Shimizu Y; Shimizu S; Kitagawa K
Mult Scler; 2018 Aug; 24(9):1212-1223. PubMed ID: 28657431
[TBL] [Abstract][Full Text] [Related]
20. Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study.
Chew SH; Achmad Sankala HB; Chew E; Md Arif MHB; Mohd Zain NR; Hashim H; Koya Kutty SB; Chee YC; Mohd Saleh NB; Ong BH; Viswanathan S
Mult Scler Relat Disord; 2023 Nov; 79():104992. PubMed ID: 37717306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
